Skip to main content
. 2016 Aug 1;27(15):2404–2422. doi: 10.1091/mbc.E16-03-0191

TABLE 2:

Polypeptide ratios in WT and d1blic (RNAi-A) flagella determined by iTRAQ analysis.

Experiment 1 Experiment 2
Polypeptide Chlamydomonas genome ID (V5.5) Peptides WT/WT d1blic/WT Peptides WT/WT d1blic/WT
Decreased
 Retrograde motor
  DHC1b Cre06.g250300 89 (241) 1.01 0.39, 0.34 191 (248) 1.04 0.27, 0.29
  FAP133/D1bIC2 Cre02.g110950 4 (7) 1.00 0.61, 0.51 11 (13) 1.05 0.35, 0.36
  FAP163/D1bIC1 Cre10.g428664 7 (10) 0.97 0.44, 0.51 17 (18) 1.02 0.37, 0.36
  D1bLIC Cre09.g398882 11 (32) 1.00 0.31, 0.29 18 (25) 1.07 0.32, 0.29
 Anterograde motor
  FLA10 Cre17.g730950 14 (37) 1.02 0.81, 0.70 56 (55) 1.07 0.48, 0.48
  FLA8 Cre12.g522550 17 (36) 1.03 0.82, 0.88 46 (57) 1.07 0.53, 0.52
  KAP Cre10.g449250 10 (26) 1.00 0.84, 0.66 31 (35) 1.01 0.47, 0.48
 Other
  RSP17 Cre07.g340400 20 (52) 1.02 0.35, 0.35 36 (48) 1.04 0.42, 0.34
  WNK1 Cre17.g700133 6 (14) 1.00 0.61, 0.65 6 (7) 1.07 0.31, 0.33
  FAP24 Cre02.g081050 12 (34) 1.02 0.70, 0.46 35 (35) 1.01 0.45, 0.52
  PKD2 Cre17.g715300 13 (39) 1.03 0.71, 0.48 32 (34) 1.05 0.75, 0.73
  FAP5 Cre16.g687966 34 (126) 1.00 0.74, 0.61 57 (67) 1.06 0.34, 0.36
  FAP208 Cre11.g482001 43 (116) 1.04 0.77, 0.71 82 (108) 1.05 0.37, 0.36
  TPR protein Cre17.g747247 58 (121) 1.02 0.79, 0.64 109 (123) 1.05 0.41, 0.41
  FAP26 Cre04.g215250 21 (42) 1.02 0.87, 0.58 45 (48) 1.04 0.77, 0.72
  FAP48/IP3R Cre16.g665450 61 (199) 1.00 0.92, 0.78 122 (139) 1.03 0.79, 0.79
Increased
 IFT complex A
  IFT144 (FAP66) Cre13.g572700 56 (176) 1.02 1.56, 1.28 92 (101) 1.00 1.93, 1.82
  IFT140 Cre08.g362650 50 (159) 1.04 1.62, 1.36 99 (99) 0.99 1.90, 1.83
  IFT139 (FAP60) Cre06.g268800 68 (214) 1.02 1.56, 1.45 99 (98) 0.99 1.89, 1.77
  IFT121 (FAP118) Cre11.g475000 42 (118) 1.04 1.55, 1.40 62 (61) 0.99 2.09, 1.99
  IFT43 Cre06.g251200 4 (9) 0.96 1.43, 1.00 17 (22) 1.01 1.78, 1.66
 IFT complex B
  IFT172 Cre17.g703900 86 (244) 1.04 1.59, 1.44 171 (158) 0.98 1.76, 1.67
  IFT88 Cre07.g335750 36 (115) 1.05 1.59, 1.76 71 (86) 0.99 1.80, 1.70
  IFT81 Cre17.g723600 38 (123) 1.02 1.60, 1.66 68 (88) 1.03 1.71, 1.58
  IFT80 Cre03.g204150 29 (80) 1.01 1.58, 1.21 41 (42) 0.99 1.83, 1.85
  IFT74/72 Cre01.g027950 41 (149) 1.02 1.61, 1.56 88 (101) 1.00 1.82, 1.70
  IFT70/TPR5 Cre07.g342200 26 (77) 1.03 1.57, 1.78 45 (59) 1.00 1.84, 1.85
  IFT57 Cre10.g467000 18 (60) 1.00 1.61, 1.82 36 (38) 0.98 1.74, 1.55
  IFT56 (DYF13) Cre11.g467616 25 (50) 1.00 1.59, 1.33 27 (48) 0.95 1.94, 2.04
  IFT54 (FAP116) Cre11.g467739 14 (57) 1.00 1.62, 1.76 59 (68) 1.03 1.78, 1.68
  IFT52 (BLD1) Cre04.g219250 22 (60) 0.98 1.66, 1.45 58 (66) 1.00 1.80, 1.80
  IFT46 (FAP32) Cre05.g241637 20 (51) 0.99 1.63, 1.30 34 (41) 1.01 1.77, 1.66
  IFT27 (FAP156) Cre01.g047950 8 (24) 0.99 1.53, 1.67 8 (16) 0.93 1.56, 1.44
  IFT25 (FAP232) Cre10.g450350 7 (18) 0.97 1.73, 0.88 6 (7) 0.98 1.92, 1.95
  IFT22/RabL5 Cre01.g039200 9 (16) 1.03 1.49, 0.91 22 (21) 0.97 1.60, 1.43
  IFT20 Cre02.g089950 9 (27) 0.99 1.60, 1.33 19 (21) 1.05 1.75, 1.64
  FAP22 (qilin) Cre17.g721250 14 (70) 0.98 1.78, 1.74 35 (41) 1.00 1.96, 1.78
 BBSome
  BBS1 Cre17.g741950 6 (12) 1.00 1.64, 1.23 5 (4) 0.95 1.94, 1.89
  BBS3 Cre06.g257250 8 (14) 1.00 1.63, 1.18 5 (5) 0.96 2.01, 2.01
  BBS3 Cre16.g664500 1 (3) 0.88 1.94, 2.28 11 (14) 0.97 1.85, 1.72
  BBS4 Cre12.g548650 3 (5) 1.00 1.31, 1.25 5 (4) 1.04 1.96, 1.94
  BBS5 Cre06.g267550 1 (3) 1.09 1.39, 0.95 1 (1) 1.00 0.68, 0.94
  BBS7 Cre01.g043750 6 (16) 1.01 1.68, 1.34 10 (11) 0.98 2.06, 1.80
  BBS8 Cre16.g666500 2 (7) 1.02 1.52, 2.03 2 (2) 1.01 2.17, 2.16
  BBS9 Cre04.g219700 2 (8) 0.92 1.50, 1.26 3 (2) NQ NQ
 Other
  FAP256 Cre10.g431150 10 (23) 0.98 1.29, 1.39 14 (17) 0.95 1.49, 1.34
  RB47 Cre01.g039300 6 (9) 0.98 1.31, 1.51 6 (8) 1.00 2.3, 2.12
  tRNA synthetase Cre02.g143200 4 (6) 1.09 1.42, 1.72 14 (13) 1.04 1.32, 1.18
  HSP90A Cre09.g386750 6 (12) 1.00 1.42, 1.46 8 (13) 1.00 1.47, 1.38
  ABC4 Cre04.g222700 13 (19) 1.01 1.44, 1.35 42 (48) 1.06 1.32, 1.25
  GDP-d-mannose phosphorylase Cre16.g672800 3 (3) 0.94 1.61, 1.56 2 (4) 0.99 1.63, 1.50
  GST Cre16.g682725 4 (10) 1.02 1.71, 1.83 6 (7) 1.03 1.47, 1.70
  FAP295 Cre16.g663200 41 (138) 1.03 1.79, 1.71 44 (61) 1.02 1.89, 1.71
  PRX2 Cre02.g114600 17 (56) 1.00 1.95, 2.54 33 (47) 0.98 1.57, 1.45
  FAP179/GST Cre17.g742300 17 (45) 1.02 2.08, 2.42 21 (24) 0.93 3.35, 3.30
  ICL1 Cre06.g282800 25 (102) 1.09 2.62, 2.62 93 (86) 0.97 2.53, 2.30
  Unknown Cre05.g239500 25 (45) 1.02 2.30, 1.68 32 (38) 0.89 5.52, 5.19

Peptides refers to the number of peptides identified at 95% confidence and the number of peptides used for iTRAQ quantification. Both WT and mutant samples were analyzed in duplicate. WT/WT ratios typically varied <10%. Mutant/WT ratios that were statistically significant (p < 0.05) are shown in bold type. NQ = not quantified.